EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study

Riley E Kemna, Paul J Kueck, Anneka Blankenship, Casey S John, Chelsea N Johnson, Zachary D Green, Hana Mayfield, Lauren Yoksh, Lance Johnson, John P Thyfault, Jonathan D Mahnken, Benjamin F Miller und 1 weitere

Alzheimer's & Dementia · 2025-12 · 21 (12)

DOI: 10.1002/alz.70984 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 10.12.2025. Verfasst von Riley E Kemna und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Kansas Alzheimer's Disease Research Center, Fairway, Kansas, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognition, Cognitive Dysfunction, Lactic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, The Margaret "Peg" McLaughlin and Lydia A. Walker Opportunity Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Impaired cerebral glucose metabolism is a hallmark of Alzheimer's disease (AD). Lactate is an alternative brain fuel; however, whole‐body lactate metabolism has not been measured in AD. METHODS The Lactate for Energy and Neurocognition Trial (NCT05207397) was a single‐arm trial that enrolled 24 cognitively healthy (CH) older adults and 12 cognitively impaired (CI) participants. Subjects underwent a stable isotope lactate infusion to evaluate lactate metabolism, cognitive testing, and blood biomarker analyses. pTau217, brain‐derived tau (BD‐tau), pTau181, glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), total tau, and brain‐derived neurotrophic factor (BDNF) were analyzed by Simoa HD‐X (Quanterix). RESULTS Lactate metabolic clearance rate did not differ between CH and CI subjects ( p = 0.988). After infusion, global cognition was improved ( p < 0.001) and plasma pTau217 (−33.8%, p < 0.001), BD‐tau (−32.6%, p < 0.001), pTau181 (−21.4%, p < 0.001), GFAP (−39.7%, p < 0.001), and NfL (−19.5%, p < 0.001) were reduced. CONCLUSIONS Lactate turnover was not different between diagnosis groups. Lactate infusion improved cognition and reduced AD fluid biomarkers. Highlights Individuals with Alzheimer's disease (AD) can metabolize lactate as well as healthy controls. Lactate infusion might improve global cognition and processing speed. Lactate infusion results in significant decrease of AD fluid biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitionCognitive DysfunctionLactic AcidAgedFemaleHumansMaleBiomarkersBrain-Derived Neurotrophic FactorGlial Fibrillary Acidic ProteinNeuropsychological Teststau Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseagingexercisefluid biomarkerslactatemetabolism

Substanzen

BiomarkersBrain-Derived Neurotrophic FactorGlial Fibrillary Acidic ProteinLactic Acidtau Proteins

Autor:innen und Institutionen

  • University of Kansas Alzheimer's Disease Research Center, Fairway, Kansas, USA.
  • Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Department of Physiology, University of Kentucky, Lexington, Kentucky, USA.
  • Sanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.

Förderung

  • NIA NIH HHS
  • NIH HHS
  • The Margaret "Peg" McLaughlin and Lydia A. Walker Opportunity Fund
  • Alzheimer's Association
  • The University of Kansas Alzheimer's Disease Research Center
  • the CNS Metabolism COBRE
  • National Institutes of Health

Zitieren

APA

Kemna, R. E., Kueck, P. J., Blankenship, A., John, C. S., Johnson, C. N., Green, Z. D., Mayfield, H., Yoksh, L., Johnson, L., Thyfault, J. P., Mahnken, J. D., Miller, B. F., & Morris, J. K. (2025). Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study. Alzheimer's & Dementia, 21(12). https://doi.org/10.1002/alz.70984

Vancouver

Kemna RE, Kueck PJ, Blankenship A, John CS, Johnson CN, Green ZD, et al. Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study. Alzheimer's & Dementia. 2025;21(12). doi:10.1002/alz.70984

BibTeX
@article{Kemna2025,
  author = {Kemna, Riley E and Kueck, Paul J and Blankenship, Anneka and John, Casey S and Johnson, Chelsea N and Green, Zachary D and Mayfield, Hana and Yoksh, Lauren and Johnson, Lance and Thyfault, John P and Mahnken, Jonathan D and Miller, Benjamin F and Morris, Jill K},
  title = {Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {12},
  doi = {10.1002/alz.70984}
}
Kostenlos starten →